0.17
전일 마감가:
$0.1748
열려 있는:
$0.1925
하루 거래량:
61,637
Relative Volume:
0.20
시가총액:
$5.15M
수익:
-
순이익/손실:
$-4.23M
주가수익비율:
-0.8065
EPS:
-0.2108
순현금흐름:
-
1주 성능:
-5.92%
1개월 성능:
+9.54%
6개월 성능:
-61.10%
1년 성능:
+0.00%
Klotho Neurosciences Inc Stock (KLTO) Company Profile
명칭
Klotho Neurosciences Inc
전화
646-916-5315
주소
1115 BROADWAY, NEW YORK
KLTO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
KLTO
Klotho Neurosciences Inc
|
0.17 | 5.15M | 0 | -4.23M | 0 | -0.2108 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.12 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
657.73 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
271.61 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.07 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Klotho Neurosciences Inc 주식(KLTO)의 최신 뉴스
Klotho Neurosciences Inc (KLTO) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Investing in Klotho Neurosciences Inc (KLTO) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com
Form PRE 14AOther preliminary proxy statements - ADVFN
Klotho Neurosciences faces Nasdaq delisting risk By Investing.com - Investing.com South Africa
Klotho Neurosciences faces Nasdaq delisting risk - Investing.com
Klotho Neurosciences receives Nasdaq compliance extension By Investing.com - Investing.com India
Klotho Neurosciences receives Nasdaq compliance extension - Investing.com Australia
KLTO stock touches 52-week low at $0.19 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary By Investing.com - Investing.com South Africa
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary - Investing.com
Klotho Neurosciences, Inc. SEC 10-K Report - TradingView
Klotho Neurosciences Inc. (KLTO) reports earnings - qz.com
KLTO stock touches 52-week low at $0.25 amid sharp annual decline - Investing.com Canada
Exelixis (NASDAQ:EXEL) & Klotho Neurosciences (NASDAQ:KLTO) Financial Analysis - Defense World
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
Klotho Neurosciences faces Nasdaq delisting By Investing.com - Investing.com Australia
Klotho Neurosciences faces Nasdaq delisting - Investing.com India
Citigroup Begins Coverage on Candel Therapeutics (NASDAQ:CADL) - Defense World
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Klotho Neurosciences secures $2M in convertible notes and warrants By Investing.com - Investing.com Canada
Klotho Neurosciences secures $2M in convertible notes and warrants - Investing.com India
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - The Manila Times
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences secures $1.2 million convertible note By Investing.com - Investing.com Canada
Klotho Neurosciences secures $1.2 million convertible note - Investing.com India
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts - GlobeNewswire
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board - Yahoo Finance
Former Merck USA President Joins Klotho Neurosciences' Board of Directors - The Manila Times
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors - GlobeNewswire
Klotho Neurosciences Taps Former Merck US President Who Led $12B Portfolio to Board of Directors - StockTitan
Riad El-Dada Joins Klotho Neurosciences’ Board of Directors - citybiz
Klotho Neurosciences expands Board with seasoned healthcare executive By Investing.com - Investing.com Canada
Klotho Neurosciences expands Board with seasoned healthcare executive - Investing.com
Klotho Neurosciences, Inc. and Teleost Biopharmaceuticals, LLC Terminate Licensing Agreement - Marketscreener.com
EDIT Stock Drops Amid Market Volatility in Biotech Sector - GuruFocus
Klotho Neurosciences Inc (KLTO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):